SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that, as envisaged in the Company’s Admission Document dated 29 March 2017, it has agreed an eight month extension to its research contract with the University of Manchester to June 2018. This contract extension includes provision for the appointment of a second technician to the Company. This will increase the Company’s ability to develop its SkinBiotix® platform.
Cancer patients being treated with a specific type of immunotherapy may be at greater risk from adverse events after the annual influenza injection, research suggests.
Steve Larratt, Share Research Business Analyst at Share Talk, presents the outlook for Rockhopper Exploration PLC (RKH.L) and N4 Pharma PLC (N4P.L). Steve talks to Tip TV’s Zak Mir.
N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the readmission today of the Company’s ordinary shares to trading on AIM and the commencement of dealings in the New Ordinary Shares under the ticker N4P (“Admission”).
Share Talk took the opportunity to speak with N4 Pharma’s Founder and CEO Nigel Theobald following their admission and first day of shares being available for dealing on AIM .
Verditek plc, a holding company with three businesses operating within the clean technology sector with proven products considered as being at the point of commercialisation, is pleased to announce its intention to seek admission of its shares to trading on the AIM market of the London Stock Exchange (“Admission”). Dealings are expected to commence on AIM in May 2017.
Welcome to Steve Shares. This publication is an interactive weekly update on what’s happening over social media and the trending stocks that have made the news this week. I highlight and comment on the coming news and events in connection with the trending stocks. I provide a round up of Share Talk’s key company interviews over the last week. If you think that a certain share or a key news item should be reported on be in the next edition, let me know by contacting me. My details are at the bottom of the page…
The trade body representing medicines manufacturers has called on the next government to bring the UK’s current healthcare spending of 9.9% of GDP into line with the G7 average of 11.3%, in order to help the NHS become one of the best health services in the world.
Watch Steve Larratt, Share Research Business Analyst at Share Talk, discuss the outlook for Eco (Atlantic) Oil & Gas, Venture Life and Petroneft. Larratt talks to Tip TV Presenter Zak Mir.